OverT Bio operates as a biotech company that provide cell therapy for cancers.
OverT Bio has raised $120K in total funding. The most recent round was Grant. The last funding was announced in November 2024.
OverT Bio's investors include Gaingels, Fusion Fund, Wing Venture Capital, Civilization Ventures, OMX Ventures.
OverT Bio is headquartered in New York, United States.
OverT Bio operates as a biotech company that provide cell therapy for cancers.
OverT Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OverT Bio — Funding & Investors." VCBacked, November 22, 2024, https://www.vcbacked.co/company/overt-bio. Accessed August 2, 2026.
VCBacked. (2024). OverT Bio — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/overt-bio
{{cite web |title=OverT Bio — Funding & Investors |url=https://www.vcbacked.co/company/overt-bio |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated